Tag Archives: transplant

The Contribution of Donor Quality to Differential Graft Survival in African American and Caucasian Renal Transplant Recipients Authors undertook this study to determine the presence of and any possible contributing factors to differences in donor quality between African American and … Continue reading →

Outcomes of Liver Transplant Recipients
 with Hepatitis C and Human Immunodeficiency Virus Coinfection Authors hypothesized that the outcomes of HCV/HIV-coinfected patients would be similar to the outcomes of other higher risk LT recipients without HIV, such as recipients who are … Continue reading →

Pregnancy Outcomes of Liver Transplant Recipients: A Systematic Review
and Meta-Analysis The goals of this study were to systematically identify all studies of pregnancy-related outcomes for LT recipients and estimate the rates of pregnancy events, obstetric complications, and delivery outcomes and … Continue reading →

Are Patients With Child’s A Cirrhosis and Hepatocellular Carcinoma Appropriate Candidates for Liver Transplantation? Authors aimed to estimate the survival benefit derived from transplantation in patients with stage II hepatocellular carcinoma (HCC) and Child’s A cirrhosis, defined as the mean … Continue reading →

Outcome of HCV/HIV-Coinfected Liver Transplant Recipients: A Prospective and Multicenter Cohort Study Eighty-four HCV/HIV-coinfected and 252-matched HCV-monoinfected liver transplant recipients were included in a prospective multicenter study. Thirty- six (43%) HCV/HIV-coinfected and 75 (30%) HCV- monoinfected patients died, with a … Continue reading →

Diabetes Mellitus Following Liver Transplantation in Patients with Hepatitis C Virus: Risks and Consequences HCV has gained proportions of a global endemic with an estimated 180- million people affected worldwide.  It is the leading indication for liver transplantation in the western … Continue reading →

Sirolimus Conversion Regimen Versus Continues Calcineurin Inhibitors in Liver Allograft Recepients. A Randomised Trial Calcinurin inhibitors (CNI) are the main stay of immunosuppression regimens following solid organ transplantation and are associated with improved patient survival and decreased acute cellular rejection … Continue reading →